Blom, D., Averna, M., Meagher, E., Toit Theron, H., Sirtori, C., Hegele, R., et al. (2017). Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia. CIRCULATION, 136(3), 332-335 [10.1161/CIRCULATIONAHA.117.028208].
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia
Averna, MaurizioWriting – Review & Editing
;
2017-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia..pdf
Solo gestori archvio
Descrizione: Articolo principale
Tipologia:
Versione Editoriale
Dimensione
195.26 kB
Formato
Adobe PDF
|
195.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
